Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Merck
Daiichi Sankyo
Teva
Medtronic
Cantor Fitzgerald
Federal Trade Commission
Moodys
Express Scripts
Johnson and Johnson

Generated: February 24, 2018

DrugPatentWatch Database Preview

CLONIDINE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clonidine and what is the scope of clonidine patent protection?

Clonidine
is the generic ingredient in nine branded drugs marketed by Boehringer Ingelheim, Actavis Labs Ut Inc, Aveva, Mayne Pharma, Mylan Technologies, Tris Pharma Inc, Exela Pharma Scs Llc, Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Zydus Pharms Usa Inc, Mylan Institutional, Actavis Elizabeth, Ajanta Pharma Ltd, Amneal Pharms Ny, Anchen Pharms, Jubilant Generics, Lupin Ltd, Xiamen Lp Pharm Co, Concordia Pharms Inc, Alembic Pharms Ltd, Am Therap, Aurolife Pharma Llc, Chartwell Molecules, Duramed Pharms Barr, Frontida Biopharm, Impax Labs, Interpharm, Mylan, Par Pharm, Prinston Inc, Sun Pharm Inds Inc, Teva, Unichem, Warner Chilcott, Watson Labs, and Yung Shin Pharm, and is included in sixty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for clonidine. Nine suppliers are listed for this compound.
Pharmacology for CLONIDINE
Medical Subject Heading (MeSH) Categories for CLONIDINE

US Patents and Regulatory Information for CLONIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurolife Pharma Llc CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070886-001 Aug 31, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Technologies CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 076166-003 Jul 16, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Yung Shin Pharm CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 202297-003 Jun 13, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Concordia Pharms Inc KAPVAY clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022331-003 Sep 28, 2010 AB1 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Am Therap CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070883-001 Jul 8, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Yung Shin Pharm CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 202297-001 Jun 13, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mayne Pharma CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 079090-001 Aug 20, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Ut Inc CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 090873-003 May 6, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Exela Pharma Scs Llc CLONIDINE HYDROCHLORIDE clonidine hydrochloride INJECTABLE;INJECTION 203167-002 Oct 29, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 090329-003 Jul 3, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CLONIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-1 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-001 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-1 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-001 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-1 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-001 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Fish and Richardson
Julphar
Boehringer Ingelheim
AstraZeneca
US Department of Justice
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot